000 01152 a2200385 4500
005 20250518073656.0
264 0 _c20200113
008 202001s 0 0 hun d
022 _a2060-0399
040 _aNLM
_beng
_cNLM
100 1 _aNyíri, Kinga
245 0 0 _a[Allele-specific inhibitors of mutant KRAS are in the focus of RASopathy consortium].
_h[electronic resource]
260 _bMagyar onkologia
_c12 2019
300 _a310-323 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAlleles
650 0 4 _aHumans
650 0 4 _aMutation
650 0 4 _aNeoplasms
650 0 4 _aProto-Oncogene Proteins p21(ras)
700 1 _aKoppány, Gergely
700 1 _aPálfy, Gyula
700 1 _aVida, István
700 1 _aTóth, Szilárd
700 1 _aOrgován, Zoltán
700 1 _aRanđelović, Ivan
700 1 _aBaranyi, Marcell
700 1 _aMolnár, Eszter
700 1 _aKeserû, Miklós György
700 1 _aTóvári, József
700 1 _aPerczel, András
700 1 _aVértessy, Beáta G
700 1 _aTímár, József
773 0 _tMagyar onkologia
_gvol. 63
_gno. 4
_gp. 310-323
999 _c30405191
_d30405191